CCL2 and hepatocellular carcinoma: It seems that C1653T mutation leads to HCC by promoting fibrosis and intracellular ROS production and changing the expression of monocyte chemotactic protein 1 (MCP-1) and interleukin 18 in the HepG2 cell line (Zhang et al., 2022).